Eisai Co. CEO Haruo Naito hailed the significant step in the battle against dementia after the Alzheimer’s treatment Lecanemab was formally approved by the Health, Labor and Welfare Ministry on Monday.
Eisai CEO Hails Significant Step in Fight Against Dementia
- Post author:Randy Banks
- Post published:October 1, 2023
- Post category:News